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Regulation of Liver Size and Regeneration: 
Importance in Liver Transplantation 
A. Francavilla, P. Ove, L. Polimeno, M. Coetzee, L. Makowka, M. Barone, 
D.H. Van Thiel, and T.E. Starzl 
T HE LIVER, under normal conditions, presents only one mitosis per 1,000 hepa-
tocytes, and the cells contain a fair amount of 
glycogen, lipids, and proteins. 
Table 1 indicates the two types of factors 
controlling normal liver physiology. It is very 
difficult to define the exact role of each of 
these factors because they are very closely 
interrelated. The typical alterations induced 
by a portacaval shunt constitute the best dem-
onstration of the existence of these two types· 
of factors. 1,2 In fact, in addition to the typical 
signs of atrophy in this model, the presence of 
regeneration with increases in the number of 
mitosis from 1.14 to 6 can be observed. The 
appearance of atrophy and ultrastructural 
deterioration demonstrates a lowering of fac-
tors controlling the size and morphology of the 
liver, and the latter indicates the appearance 
of regulating factors of regeneration. 
In a series of investigations during 1971 to 
1977,3'5 we have established that insulin is the 
main factor that regulates the size, morpholo-
gy, and structure of the liver. In fact, a 
nonhypoglycemic insulin infusion into the 
ligated left portal vein for four days after an 
Eck fistula greatly reduced the left lobular 
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hepatocyte atrophy, preserved the hepatocyte 
ultrastructure, and increased the cell renewal 
(mitosis rose from six to 15 per 1,000 cells). 
This effect was not changed by the addition of 
glucagon, regardless of the dose. The finding 
that insulin increased the number of mitoses 
raised the question of the importance of hor-
mones in the regeneration process. 
After this study, several authors6•10 have 
described hormonal changes in both rats and 
dogs, ie, decreases in'insulin, triiodothyronine, 
thyroxine, and calcitonin levels, whereas glu-
cagon and corticosterone levels increase. Fur-
thermore, we have recently reported that sex-
ual hormones are involved in liver regenera-
tion after 70% hepatectomy in rats. ll - D 
Estrogen levels increase in the serum with a 
corresponding increase in estrogen receptors, 
which correlates with the peak of the mitotic 
index. On the other hand, serum testosterone 
and androgen receptors display a very signifi-
cant decrease. 
On the basis of these hormonal changes, 
many speculations have been proposed to 
attempt to define the role of hormones in liver 
regeneration. Nevertheless, none of these 
hypotheses were conclusive for the following 
reasons: (I) it is possible to prevent the typical 
insulin-glucagon change after hepatectomy by 
glucose infusion without affecting liver re-
generation in a major way; (2) insulin and 
Table 1. Factors Regulating liver Size 
and Regeneration 
Factors for 
Li_ Throphism 
Hepatocyte content 
Glycogen 
lipids 
Vitamins 
Electrolytes 
Hepatocyte structures 
Factors for 
Li_ Regeneration 
Rapid activation of hepato-
cyte spontaneous re-
newal to maintain liver 
mass constant 
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Table 2. Tissue and Serum Growth Factors 
Time Name of Purification Molecular 
Investigator Period Substance (fold) Weight (kd) 
Tissue factors 
Blomquist 1957 
LaBrecque 1975-19B7 HSS 110,000 14-15 
Hatase 1979 30 
Starzl 1979 
Goldberg 1980-1985 Hepatopoietin 13,000 38 
Terblanche 1980 
Francavilla 1981-1987 HSS 38,000 15-50 
Schwarz 1985 14-25 
Weberman 1984 
Fleig 1986 
Serum factors 
Morley 1973 400,000 26 
Michalopoulos 1984-1986 HPTA 120 
HPTB 3 
Russell 1984 65 
Nakamura 1984 Hepatotrophin 20,000 120 
Goldberg 1980-1985 Hepatopoietin 13,000 38 
Diaz-Gil 1986 HP 83,000 64 
Abbreviations: HPTA, hapatopoietin A; HPTB, hepatopoietin B; HP, hepatic DNA-synthesis promoter. 
glucagon in vitro do not affect hepatocyte 
proliferation; (3) triiodothyronine, thyroxine, 
calcitonin, and sex hormones in vitro do not 
show particular activity on hepatocyte prolif-
eration; (4) the administration of all these 
hormones in animals after hepatectomy has 
never provided consistent data on liver regen-
eration; and finally (5) and even of further 
importance are the results we have obtained 
by transplanting small livers into much larger 
recipients. A rapid growth of small livers 
occurs during the first day after transplanta-
tion, which is similar to that observed after 
partial hepatectomy. None of the typical hor-
monal alterations observed after hepatectomy 
occurred during this process. 
Because hormonal changes did not provide 
any conclusive answers as related to liver 
regeneration, in 1975 several investigations on 
growth factors in serum and tissue were ini-
tiated. 
Table 2 illustrates the growth factors that 
have been partially isolated from serum l4-19 
and liver. 19-32 As reported in Table 2, we have 
been working on the extraction and purifica-
tion of hepatic stimulator substance (HSS) 
Table 3. Steps in the Purification of HSS and Chemical and Physicochemical Properties of Fraction F'60 Obtained 
From Weanling Rat Liver 
Protein Injected DNA Resistant to 
in Each Rat Synthesis Neuroam- Purification 
Material (mg/2mL) (cpm/mg DNA)- Heat Trypsin inidase (fold) 
Cytosol 75 43,350 ± 8,820t 
65 0 C supernatant 20 56,720 ± 10,24Ot 6 
OH-F 10 66,350 ± 11 ,350t 15 
30Kd 2_75 63,520 ± 13,220t 102 
F,OG 0.003 54,380 ± 10,200 100% 30% 100% 38,100 
-[3H)thymidine incorporation in a 40% hepatectomized rat injected with phosphate-buffered saline was 16,500 cpm/mg 
DNA. The numbers are the averages from no less than 20 different rats ± SD. 
tSignificantly different from controls, P < .05. 
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Fig 1. Dose response curve in 40% hepatectomized 
rats injected with FlIo' F,IO was injected intraperitone-
ally six hours after operation. ['HIThymidine incorpora-
tion. percentage of labeled nuclei and percentage of 
mitosis were determined 24 hours after operation .• P < 
.05. 
since 1980. HSS was first described by 
LaBrecque and Pesch20 in the cytosol of par-
tially hepatectomized rats and subsequently 
identified in canine liver by Starzl et al. 22 
Table 3 reports the steps in the purification 
and the physicochemical characteristics of the 
active chromatographic fraction, referred to 
as FIso. that is obtained from weanling rat liver 
cytosol using fast protein liquid chromatogra-
phy (FPLC) apparatus. This fraction stimu-
lated DNA synthesis in hepatocytes in a dose-
dependent regimen when injected in 40% 
hepatectomized rats (Fig 1). The activity of 
this fraction is organ specific but not species 
specific.33 
Similar to the findings with hormones, the 
considerable knowledge .obtained on growth 
factors has not yet resulted in any conclusive 
theory on liver regeneration. A better under-
standing of this process is clinically very 
important, not only for cases of liver damage 
but also for hepatic transplantation. 
It has been observed that in clinical liver 
transplantation a liver from a small donor, 
occasionally transplanted into a much larger 
recipient, rapidly increases in size and 
achieves a size comparable to that of a normal 
liver for that particular recipient in a period of 
2 weeks. These phenomena have been exten-
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Fig 2. Change in liver volume after transplantation. 
The growth of a small-for-size liver transplanted in a 
large recipient 1.1 and the growth of a normal liver 
transplanted in a recipient of similar size 1il.1 are 
expressed as a percentage of the initial volume. 
sively studied in dogs in which small-for-size 
livers were transplanted into larger recip-
ients. 34 
In Fig 2, the increase in the volume of a 
small liver transplanted in a larger animal is 
compared with that of a normal-for-size liver 
transplanted into a dog of suitable size. 
A great increase in thymidine kinase, orni-
thine, and decarboxylase levels and in the 
percentage of mitoses was detected only in the 
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Fig 3. Plasma insulin and plasma glucagon levels in 
the two groups of animals: •• small-for-size liver trans-
planted in large recipient: o. normal liver transplanted in 
a recipient of similar size. 
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small liver transplanted in a host of a larger 
size. This indicates an active hepatocyte pro-
liferation. Figure 3 compares the insulin glu-
cagon changes observed in both models. 
Despite a different rate of hepatocyte prolifer-
ation, the hormonal changes observed were 
similar but at the same time different from the 
levels observed in a regenerating liver induced 
by partial hepatectomy.3 
In this experiment, the lack of specific 
hormonal changes suggests that the role of 
hormones in liver regeneration has to be 
reevaluated, and it raises the question of the 
existence of inhibitors as additional factors of 
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liver growth regulation. A small liver, when 
transplanted into a large animal, might be 
unable to produce enough inhibitor substance 
to keep a normal plasma concentration. 
Therefore, regeneration could be seen as a 
complex mechanism in which the initiating 
key is the plasma concentration of inhibitors. 
This possibility even further complicates the 
already complex view of the regeneration pro-
cess. In fact, we know only a few pieces of the 
puzzle that are responsible for the complex 
system of regeneration, and even more dis-
couraging, we do not fully understand how all 
these pieces fit together. 
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